Innovative MedTech Files 8-K on Agreements & Acquisitions

Ticker: IMTH · Form: 8-K · Filed: May 1, 2025 · CIK: 1331612

Innovative Medtech, Inc. 8-K Filing Summary
FieldDetail
CompanyInnovative Medtech, Inc. (IMTH)
Form Type8-K
Filed DateMay 1, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, acquisition, equity-sale

TL;DR

IMTH filed an 8-K detailing material agreements, asset deals, and equity sales.

AI Summary

Innovative MedTech, Inc. filed an 8-K on April 25, 2025, reporting on several key events. These include entering into a material definitive agreement, the completion of an acquisition or disposition of assets, and unregistered sales of equity securities. The filing also contains Regulation FD disclosures and financial statements/exhibits.

Why It Matters

This 8-K filing signals significant corporate actions by Innovative MedTech, Inc., including potential strategic acquisitions or divestitures and equity transactions that could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — The filing indicates material definitive agreements, asset transactions, and unregistered equity sales, which can introduce financial and operational risks.

Key Players & Entities

  • Innovative MedTech, Inc. (company) — Registrant
  • April 25, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • Fresh Harvest Products, Inc. (company) — Former Company Name
  • Serino 1, Corp. (company) — Former Company Name
  • Serion 1, Corp. (company) — Former Company Name

FAQ

What specific material definitive agreement did Innovative MedTech, Inc. enter into?

The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.

What was the nature of the acquisition or disposition of assets?

The filing reports the completion of an acquisition or disposition of assets, but the specifics of the transaction are not detailed in the provided text.

What were the circumstances of the unregistered sales of equity securities?

The filing mentions unregistered sales of equity securities, but the details regarding the amount, price, or recipients of these sales are not specified in the provided text.

What is the primary business of Innovative MedTech, Inc. according to its SIC code?

Innovative MedTech, Inc.'s Standard Industrial Classification (SIC) code is 8090, which corresponds to Services-Misc Health & Allied Services, NEC.

When was the company formerly known as Fresh Harvest Products, Inc.?

The company was formerly known as Fresh Harvest Products, Inc. prior to a name change on January 30, 2006.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding INNOVATIVE MEDTECH, INC. (IMTH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.